Literature DB >> 24438016

Outlook for a dengue vaccine.

R Norrby1.   

Abstract

Dengue is an increasing medical problem in subtropical and tropical countries. The search for a safe and effective vaccine is complicated by the fact that there are four types of dengue virus and that, if a vaccine is live attenuated, it should be proven not to cause the life-threatening form of dengue, dengue haemorrhagic fever. So far one vaccine candidate, a four-valent chimeric vaccine constructed from a yellow fever vaccine strain, has reached large clinical trials and has been shown to offer protection against dengue types 1, 3 and 54 but not against dengue type 2. It is highly likely that an effective vaccine will be available in the next decade.
© 2013 The Authors Clinical Microbiology and Infection © 2013 European Society of Clinical Microbiology and Infectious Diseases.

Entities:  

Keywords:  Dengue; clinical trial; dengue epidemiology; dengue haemorrhagic fever; dengue vaccine

Mesh:

Substances:

Year:  2014        PMID: 24438016     DOI: 10.1111/1469-0691.12442

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  8 in total

Review 1.  Recent Advances in Dengue: Relevance to Puerto Rico.

Authors:  David H Noyd; Tyler M Sharp
Journal:  P R Health Sci J       Date:  2015-06       Impact factor: 0.705

2.  Novel synthetic 3'-untranslated regions for controlling transgene expression in transgenic Aedes aegypti mosquitoes.

Authors:  Keun Chae; Collin Valentin; Emma Jakes; Kevin M Myles; Zach N Adelman
Journal:  RNA Biol       Date:  2021-08-31       Impact factor: 4.766

3.  Recombinant vesicular stomatitis virus-based dengue-2 vaccine candidate induces humoral response and protects mice against lethal infection.

Authors:  Flavio Lauretti; Anasuya Chattopadhyay; Rafael Freitas de Oliveira França; Luiza Castro-Jorge; John Rose; Benedito A L da Fonseca
Journal:  Hum Vaccin Immunother       Date:  2016-05-16       Impact factor: 3.452

4.  Describing the breakbone fever: IDODEN, an ontology for dengue fever.

Authors:  Elvira Mitraka; Pantelis Topalis; Vicky Dritsou; Emmanuel Dialynas; Christos Louis
Journal:  PLoS Negl Trop Dis       Date:  2015-02-03

5.  Dengue Virus NS Proteins Inhibit RIG-I/MAVS Signaling by Blocking TBK1/IRF3 Phosphorylation: Dengue Virus Serotype 1 NS4A Is a Unique Interferon-Regulating Virulence Determinant.

Authors:  Nadine A Dalrymple; Velasco Cimica; Erich R Mackow
Journal:  MBio       Date:  2015-05-12       Impact factor: 7.867

6.  Dengue Vaccines: A Perspective from the Point of View of Intellectual Property.

Authors:  Claudimar Pereira da Veiga; Cássia Rita Pereira da Veiga; Jansen Maia Del Corso; Wesley Vieira da Silva
Journal:  Int J Environ Res Public Health       Date:  2015-08-12       Impact factor: 3.390

7.  Costly Inheritance and the Persistence of Insecticide Resistance in Aedes aegypti Populations.

Authors:  Helio Schechtman; Max O Souza
Journal:  PLoS One       Date:  2015-05-01       Impact factor: 3.240

8.  First comprehensive analysis of Aedes aegypti bionomics during an arbovirus outbreak in west Africa: Dengue in Ouagadougou, Burkina Faso, 2016-2017.

Authors:  Athanase Badolo; Aboubacar Sombié; Félix Yaméogo; Dimitri W Wangrawa; Aboubakar Sanon; Patricia M Pignatelli; Antoine Sanon; Mafalda Viana; Hirotaka Kanuka; David Weetman; Philip J McCall
Journal:  PLoS Negl Trop Dis       Date:  2022-07-06
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.